We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jeremy Warner

Jeremy L. Warner MD, MS, FAMIA, FASCO

Associate Professor of Medicine, Division of Hematology and Oncology; Associate Professor of Medicine, Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee
Jeremy L. Warner MD, MS, FAMIA, FASCO is an Associate Professor of Medicine and Biomedical Informatics at Vanderbilt University. His clinical area of focus is hematologic malignancy. His primary research goal is to make sense of the structured and unstructured data present in electronic health records (EHRs) and clinical knowledge bases (CKBs) to directly improve clinical care for cancer patients. He is the Deputy Editor of HemOnc.org, the largest freely available wiki of chemotherapy regimens.

Disclosures

Disclosures: Dr. Warner consults for Westat and am co-founder of HemOnc.org LLC (shares have no monetary value). He is also on the advisory board of IBM Watson Health.